Found "HTA": 335 results
Report: Indonesian Delegation Study Visit to HITAP
The Indonesian government is strongly committed to Universal Health Coverage and acknowledges that health technology assessment (HTA) as an important tool for setting priorities for the health benefits package. Since the establishment of the HTA Committee, a number of Ministry of Health (MOH) and ac
Real-Word Evidence: How Does It Make HTA More Realistic? Is It Appropriate to Use?
Why do we need to make health technology assessment (HTA) more realistic? Is HTA not realistic nowadays?
The answers can be both YES and NO.HTA is a form of research for synthesising data to evaluate properties, effects, and impacts of health interventions and technology in diffe
Rapid Health Technology Assessment: A Cost-Utility and Budget Impact Analysis of Abiraterone Acetate for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) After Docetaxel Therapy
Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in
Priority setting for health innovation and Early Health Technology Assessment for supporting research and development of medical innovation in Thailand (Fiscal Year 2026)
The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr
Priority setting for health innovation and Early Health Technology Assessment for supporting research and development of medical innovation in Thailand (Fiscal year 2025)
The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr
Priority setting for health innovation and Early Health Technology Assessment for supporting research and development of medical innovation in Thailand
66183067HM017L0medical innovation,Early HTA,Health Technology
PRINCE MAHIDOL AWARD CONFERENCE (PMAC) 2020 SIDE EVENT “ATTAIN & SUSTAIN HEALTH GAINS: INCORPORATING VALUE-FOR-MONEY IN THE UHC DIALOGUE”
The Health Intervention and Technology Assessment Program (HITAP), a member of the International Decision Support Initiative (iDSI) organised a side meeting titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Universal Health Coverage Dialogue” at the Prince Mahidol Award
Presentation of Economic Evaluation Results (2014)
Usa Chaikledkaew BSc(Pharm), MA, PhD*,**
* Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy,
Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
** Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thail
10 / Page